Market Currents
Looking to offset a patent cliff that could cut sales by up to $2.75B this year, Pfizer (PFE) is...
-
Tuesday, January 15, 6:08 AM ETLooking to offset a patent cliff that could cut sales by up to $2.75B this year, Pfizer (PFE) is among the companies reportedly interested in acquiring Agila Specialties, the injectable-medicines unit of India's Strides Arcolab. Novartis (NVS), Mylan (MYL) and Fresenius (APCVZ) have also been eyeing Agila, which produces cancer treatments and antibiotics, and could be valued at $2B.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
